Insulet PODD Equity Method Investments
Equity Method Investments at other companies
Other financials
Where this comes from
Reported directly by Insulet in its filing.
Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.
The source filing: Insulet’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001145197-26-000169
The total carrying value of the Company’s investments in equity securities without readily determinable fair values was $19.1 million at both June 30, 2026 and December 31, 2025 and was included within other assets on the consolidated balance sheets. These investments are carried at cost less impairment, if any. If an observable price change in orderly transactions for the identical or similar investment in the same issuer is identified, the investments are measured at fair value as of the date that the observable transaction occurred and categorized as Level 2 in the fair value hierarchy.
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Insulet's equity method investments?
- Insulet (PODD) reported equity method investments of $19.1M in Q2 2026.
- How has Insulet's equity method investments changed year-over-year?
- Insulet's equity method investments decreased by 0.0% year-over-year, from $19.1M to $19.1M.
- What does equity method investments mean?
- Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.
Ask your AI about Insulet's equity method investments.
Connect your AI assistant and compare it to peers, right in your chat.
